The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Kenneth A. Bauer

VA Boston Healthcare System

Harvard Medical School

Boston

Massachusetts

USA

[email]@*.harvard.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • VA Boston Healthcare System, Harvard Medical School, Boston, Massachusetts, USA. 2003
  • Department of Medicine, Veterans Affairs Boston Healthcare System and Beth Israel Deaconess Medical Center, MA 02215, USA. 2001 - 2002
  • VA Boston Health System, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, USA. 2002
  • Hematology Section, VA Boston Healthcare System, MA 02132, USA. 2001

References

  1. Management of thrombophilia. Bauer, K.A. J. Thromb. Haemost. (2003) [Pubmed]
  2. Fondaparinux, a synthetic pentasaccharide: the first in a new class of antithrombotic agents - the selective factor Xa inhibitors. Bauer, K.A., Hawkins, D.W., Peters, P.C., Petitou, M., Herbert, J.M., van Boeckel, C.A., Meuleman, D.G. Cardiovasc. Drug. Rev (2002) [Pubmed]
  3. Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism. Bauer, K.A., Eriksson, B.I., Lassen, M.R., Turpie, A.G. Curr. Opin. Pulm. Med (2002) [Pubmed]
  4. Fondaparinux: basic properties and efficacy and safety in venous thromboembolism prophylaxis. Bauer, K.A. Am J. Orthop. (2002) [Pubmed]
  5. A new antithrombotic strategy, the selective inhibition of coagulation factors, and its importance to the orthopedic specialist. Bauer, K.A., Eriksson, B.I., Lassen, M.R., Turpie, A.G. J. South. Orthop. Assoc (2002) [Pubmed]
  6. Conventional fibrinolytic assays for the evaluation of patients with venous thrombosis: don't bother. Bauer, K.A. Thromb. Haemost. (2001) [Pubmed]
  7. Fondaparinux sodium: a selective inhibitor of factor Xa. Bauer, K.A. Am. J. Health. Syst. Pharm (2001) [Pubmed]
  8. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. Bauer, K.A., Eriksson, B.I., Lassen, M.R., Turpie, A.G. N. Engl. J. Med. (2001) [Pubmed]
 
WikiGenes - Universities